[go: up one dir, main page]

NO20000536D0 - Oligonukleotidprimere for effektiv deteksjon av Hepatitis C- virus (HCV) og metoder for anvendelse derav - Google Patents

Oligonukleotidprimere for effektiv deteksjon av Hepatitis C- virus (HCV) og metoder for anvendelse derav

Info

Publication number
NO20000536D0
NO20000536D0 NO20000536A NO20000536A NO20000536D0 NO 20000536 D0 NO20000536 D0 NO 20000536D0 NO 20000536 A NO20000536 A NO 20000536A NO 20000536 A NO20000536 A NO 20000536A NO 20000536 D0 NO20000536 D0 NO 20000536D0
Authority
NO
Norway
Prior art keywords
hepatitis
methods
virus
hcv
oligonucleotide primers
Prior art date
Application number
NO20000536A
Other languages
English (en)
Other versions
NO20000536L (no
NO329925B1 (no
Inventor
Jeffrey M Linnen
Kevin M Gorman
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of NO20000536D0 publication Critical patent/NO20000536D0/no
Publication of NO20000536L publication Critical patent/NO20000536L/no
Publication of NO329925B1 publication Critical patent/NO329925B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10—Detection mode being characterised by the assay principle
    • C12Q2565/125—Electrophoretic separation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20000536A 1999-02-03 2000-02-02 Fremgangsmate for a detektere og amplifisere HCV-RNA, oligonukleotid, primer, probe og kit. NO329925B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11849799P 1999-02-03 1999-02-03

Publications (3)

Publication Number Publication Date
NO20000536D0 true NO20000536D0 (no) 2000-02-02
NO20000536L NO20000536L (no) 2000-08-04
NO329925B1 NO329925B1 (no) 2011-01-24

Family

ID=22378970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000536A NO329925B1 (no) 1999-02-03 2000-02-02 Fremgangsmate for a detektere og amplifisere HCV-RNA, oligonukleotid, primer, probe og kit.

Country Status (13)

Country Link
US (1) US6638714B1 (no)
EP (1) EP1026262B1 (no)
JP (1) JP5450914B2 (no)
KR (4) KR100869261B1 (no)
CN (2) CN1237186C (no)
AT (1) ATE428003T1 (no)
AU (1) AU1487900A (no)
CA (1) CA2296144C (no)
DE (1) DE60041940D1 (no)
DK (1) DK1026262T3 (no)
ES (1) ES2322752T3 (no)
NO (1) NO329925B1 (no)
PT (1) PT1026262E (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121335A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
WO2002083948A1 (en) * 2001-04-12 2002-10-24 Biocore Co., Ltd. Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
JP2006516193A (ja) 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド ヒトおよび動物における病原体の迅速な同定方法
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US20120122096A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
JP4866248B2 (ja) 2004-01-23 2012-02-01 バイオメリュー・インコーポレイテッド 核酸増幅性能改良のための新規ヌクレオチド混合物
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
ES2641832T3 (es) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
GB0423552D0 (en) * 2004-10-22 2004-11-24 Hepcgen Ltd Methods
EP1869180B1 (en) 2005-03-03 2013-02-20 Ibis Biosciences, Inc. Compositions for use in identification of polyoma viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
CA2616281C (en) 2005-07-21 2014-04-22 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of mitochondrial dna variants
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
MD3300G2 (ro) * 2006-09-28 2007-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Primer oligonucleotidic pentru depistarea ARN-ului virusului hepatitei C
US8871471B2 (en) 2007-02-23 2014-10-28 Ibis Biosciences, Inc. Methods for rapid forensic DNA analysis
WO2008125117A1 (en) * 2007-04-13 2008-10-23 Hvidovre Hospital Cell culture system of a hepatitis c genotype 3a and 2a chimera
US8454974B2 (en) 2007-04-13 2013-06-04 Hvidovre Hospital Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A
EP2147118A4 (en) * 2007-04-27 2010-09-01 Eragen Biosciences Inc MATERIALS AND METHOD FOR DETECTING HEPATITIS C VIRUS
WO2008141651A1 (en) * 2007-05-18 2008-11-27 Hvidovre Hospital Efficient cell culture system for hepatitis c virus genotype 5a
US20100291544A1 (en) * 2007-05-25 2010-11-18 Ibis Biosciences, Inc. Compositions for use in identification of strains of hepatitis c virus
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
WO2009080052A1 (en) * 2007-12-20 2009-07-02 Hvidovre Hospital Efficient cell culture system for hepatitis c virus genotype 6a
WO2009087685A2 (en) * 2008-01-04 2009-07-16 Premas Biotech Pvt.Ltd Method for detection of hepatitis nucleic acid and uses thereof
US8506969B2 (en) 2008-08-15 2013-08-13 Hvidovre Hospital Efficient cell culture system for hepatitis C virus genotype 7a
WO2010017818A1 (en) 2008-08-15 2010-02-18 Hvidovre Hospital Efficient cell culture system for hepatitis c virus genotype 2b
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2344647A1 (en) 2008-10-03 2011-07-20 Hvidovre Hospital Hepatitis c virus expressing reporter tagged ns5a protein
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc IONIZATION PROBE ASSEMBLIES
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
EP2957641B1 (en) 2009-10-15 2017-05-17 Ibis Biosciences, Inc. Multiple displacement amplification
KR101503039B1 (ko) * 2010-07-01 2015-04-29 (주)바이오니아 Ｃ형 간염 바이러스 진단용 프라이머, 프로브, 이를 포함하는 키트 및 상기 키트를 이용한 ｃ형 간염 바이러스 진단 방법
WO2012019260A2 (pt) * 2010-08-11 2012-02-16 Universidade Federal Do Rio De Janeiro Molécula de rna sintética do vírus da hepatite c, processo de obtenção e uso como controle interno para quantificação e/ou identificação do vírus da hepatite c
WO2012135975A1 (zh) * 2011-04-06 2012-10-11 瑞基海洋生物科技股份有限公司 聚合酶链式反应用的混合液
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid
CN106929603A (zh) * 2017-01-10 2017-07-07 上海纽思格生物科技有限公司 一种改良型hcv rna检测试剂盒
WO2019070854A1 (en) * 2017-10-03 2019-04-11 Abbott Molecular Inc. ASSAY FOR DETECTION OF HEPATITIS C VIRUS (HCV)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk Ｃ型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
US5747244A (en) 1991-12-23 1998-05-05 Chiron Corporation Nucleic acid probes immobilized on polystyrene surfaces
JP4251407B2 (ja) * 1992-11-27 2009-04-08 イノゲネテイクス・エヌ・ブイ Ｈｃｖ単離物のタイピング法
JPH06153961A (ja) * 1992-11-27 1994-06-03 Imuno Japan:Kk Ｃ型肝炎ウイルス部分遺伝子、ならびにｃ型肝炎ウイルス遺 伝子の高感度検出法
JPH07184695A (ja) 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd Ｃ型肝炎ウイルスの簡易検出法
US5837442A (en) * 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
IT1284847B1 (it) 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv

Also Published As

Publication number Publication date
KR20000076603A (ko) 2000-12-26
AU1487900A (en) 2000-08-10
JP5450914B2 (ja) 2014-03-26
CA2296144C (en) 2008-07-29
KR20080014130A (ko) 2008-02-13
NO20000536L (no) 2000-08-04
EP1026262A2 (en) 2000-08-09
DK1026262T3 (da) 2009-07-06
KR100901086B1 (ko) 2009-06-08
KR20080014129A (ko) 2008-02-13
DE60041940D1 (de) 2009-05-20
EP1026262A3 (en) 2001-11-21
CN1237186C (zh) 2006-01-18
CN1274757A (zh) 2000-11-29
ES2322752T3 (es) 2009-06-26
KR20070052723A (ko) 2007-05-22
CN1827780A (zh) 2006-09-06
PT1026262E (pt) 2009-05-21
EP1026262B1 (en) 2009-04-08
CN100441700C (zh) 2008-12-10
NO329925B1 (no) 2011-01-24
ATE428003T1 (de) 2009-04-15
US6638714B1 (en) 2003-10-28
CA2296144A1 (en) 2000-08-03
KR100898711B1 (ko) 2009-05-21
KR100869261B1 (ko) 2008-11-18
JP2000279200A (ja) 2000-10-10

Similar Documents

Publication Publication Date Title
NO20000536D0 (no) Oligonukleotidprimere for effektiv deteksjon av Hepatitis C- virus (HCV) og metoder for anvendelse derav
NO20000513D0 (no) Oligonukleotid-reverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
DK0787807T3 (da) Primere og prober til detektion af hepatitis C
DK0776981T3 (da) Oligonucleotidprimere til amplifikation af HCV-nukleinsyre
DK1012348T3 (da) Detektion og identifikation af humant papillomavirus ved PCR og typespecifik revers hybridisering
DE69804464D1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
WO2002090572A3 (en) Nucleic acid detection in pooled samples
DE69939388D1 (de) Identizierung von microorganismen,die akute atemwegsinfektionen verursachen
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
NO20000514L (no) Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav
DE60330160D1 (de) Oligonukleotide zur Detektion von Hepatitis B Viren
HUP0103735A2 (hu) Eljárás humán hepatitis B vírus (HBV) DNS-polimeráz in vitro aktivitásának vizsgálatára, ennek alkalmazása különböző szérumminták aktivitásának elemzésére és HBV DNS-polimeráz inhibitorainak vizsgálatára, valamint eljárás HBV DNS-polimeráz előállítására
ATE305522T1 (de) Nachweis von humanen papillomviren
NO20000537D0 (no) Oligonukleotidprimere for effektiv reverstranskripsjon av Hepatitis C-virus (HCV) RNA og metoder for anvendelse derav
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees